Tham, E, Hung, R, Myers, K, et al. Optimization of myocardial nulling in pediatric cardiac MRI. Pediatr Radiol
2012; 42: 431–439.
Krishnan, A, Pike, J, Donofrio, MT. Prenatal evaluation and management of fetuses exposed to anti-SSA/Ro antibodies. Pediatr Cardiol
2012; 33: 1245–1252.
Krishnan, A, Arya, B, Moak, J, Donofrio, MT. Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center. Prenat Diagn
2014; 34: 1207–1212.
Donofrio, MT, Moon-Grady, AJ, Hornberger, LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation
2014; 129: 2183–2428.
Nield, L, Silverman, E, Smallhorn, J, et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol
2002; 40: 796–802.
Saleeb, S, Copel, J, Friedman, D, Buyon, JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum
1999; 42: 2335–2345.
Levy, R, Matitiau, A, Ben Arie, A, et al. Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus. Am J Perinatol
1999; 16: 379–383.
Takami, T, Momma, K, Imamura, S. Increased constriction of the ductus arteriosus by dexamethasone, indomethacin, and rofecoxib in fetal rats. Circulation
2005; 69: 354–358.
Latus, H, Gummel, K, Klingel, K, et al. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy. J Cardiovasc Magn Reson
2015; 17: 34.
Olivieri, LJ, Cross, RR, O’Brien, KE, et al. Free-breathing motion-corrected late-gadolinium-enhancement imaging improves image quality in children. Pediatr Radiol
2016 [Epub ahead of print].